JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB283407

Angiotensin Converting Enzyme 1 (ACE1) Assay Kit (Inhibitor Screening, Colorimetric)

Be the first to review this product! Submit a review

|

(0 Publication)

Angiotensin Converting Enzyme 1 (ACE1) Assay Kit ab283407 is a colorimetric assay designed to screen/characterize ACE1 inhibitors.

View Alternative Names

CD143, DCP, DCP1, ACE, Angiotensin-converting enzyme, Dipeptidyl carboxypeptidase I, Kininase II

1 Images
Functional Studies - Angiotensin Converting Enzyme 1 (ACE1) Assay Kit (Inhibitor Screening, Colorimetric) (AB283407)
  • FuncS

Supplier Data

Functional Studies - Angiotensin Converting Enzyme 1 (ACE1) Assay Kit (Inhibitor Screening, Colorimetric) (AB283407)

Inhibition of ACE1 activity by Captopril. IC50 was calculated to be 6.61 nM.

Key facts

Detection method

Colorimetric

Sample types

Inhibitor compounds

Assay Platform

Microplate (12 x 8 well strips)

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Enzyme activity assay": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

You may be interested in:

AB239703

ACE Assay Kit (Angiotensin I Converting Enzyme)

0

0 Reviews

View product

We recommend this product because it’s often used in the same experiment or related research.

We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.

Product details

Angiotensin Converting Enzyme 1 (ACE1) Assay Kit (Inhibitor Screening, Colorimetric) (ab283407) can be used to screen/characterize potential inhibitors of ACE1.

The kit utilizes the ability of an active ACE1 to hydrolyze a synthetic substrate, which results in the decrease in OD at 345 nm. In the presence of Captopril, an ACE1 specific inhibitor, the ACE1 enzymatic activity is greatly reduced and there is no significant decrease in the OD at 345 nm.

The assay kit provides a rapid, simple and reliable test for high-throughput screening of ACE1 inhibitors.

Other notes
This product was previously called K719 Biovision ACE1 Inhibitor Screening Kit (Colorimetric) and Angiotensin Converting Enzyme 1 (ACE1) Inhibitor Screening Kit (Colorimetric). Biovision was acquired by Abcam in 2021.

The Safety Datasheet for this product has been updated for certain countries. Please check the current version in the Support and downloads section.

What's included?

{ "values": { "100Test": { "sellingSize": "100 Test", "publicAssetCode":"ab283407-100Test", "assetComponentDetails": [ { "size":"1 x 1 Unit", "name":"96 Well UV Transparent Plate", "number":"AB283407-CMP01", "productcode":"" }, { "size":"1 x 1 Vial", "name":"Colorimetric Substrate", "number":"AB283407-CMP03", "productcode":"" }, { "size":"1 x 200 µL", "name":"ACE1 Enzyme II", "number":"AB283407-CMP04", "productcode":"" }, { "size":"1 x 25 mL", "name":"ACE Assay Buffer", "number":"AB283407-CMP02", "productcode":"" }, { "size":"1 x 100 µL", "name":"ACE1 Inhibitor", "number":"AB283407-CMP05", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Angiotensin Converting Enzyme 1 also known as ACE1 or ACE is an important enzyme in the renin-angiotensin system. This enzyme exhibits a significant role in blood pressure regulation. ACE1 is a zinc-metallopeptidase with a molecular weight of approximately 130 kDa. It converts angiotensin I into the potent vasoconstrictor angiotensin II a critical function in cardiovascular physiology. ACE1 is widely expressed in endothelial cells particularly in the lungs kidneys and the small intestine.
Biological function summary

The enzyme generates angiotensin II by cleaving angiotensin I. Angiotensin II an important effector peptide impacts cardiovascular and renal systems influencing vasoconstriction and fluid balance. While not directly forming a complex ACE1's activity increases the potency of angiotensin II which binds to angiotensin II receptors to exert its effects therefore indirectly forming a functional signaling complex.

Pathways

ACE1 plays a central role in the renin-angiotensin system and the kallikrein-kinin system. The enzyme's activity boosts angiotensin II production which connects it to the regulation of blood pressure via the renin-angiotensin pathway. ACE1 also indirectly interacts with proteins like bradykinin by degrading them modulating kinin-related functions and influencing inflammation and tension in vascular smooth muscle.

Understanding ACE1 is important for addressing hypertension and congestive heart failure. ACE1's conversion of angiotensin I to angiotensin II means overactivity can cause elevated blood pressure leading to hypertension. This makes ACE inhibitors such as lisinopril and ramipril therapeutic for these conditions. Furthermore its connection with aldosterone production places ACE1 in relevance to heart failure as excessive aldosterone can cause detrimental remodeling of cardiac tissue.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Dipeptidyl carboxypeptidase that removes dipeptides from the C-terminus of a variety of circulating hormones, such as angiotensin I, bradykinin or enkephalins, thereby playing a key role in the regulation of blood pressure, electrolyte homeostasis or synaptic plasticity (PubMed : 15615692, PubMed : 20826823, PubMed : 2558109, PubMed : 4322742, PubMed : 7523412, PubMed : 7683654). Composed of two similar catalytic domains, each possessing a functional active site, with different selectivity for substrates (PubMed : 10913258, PubMed : 1320019, PubMed : 1851160, PubMed : 19773553, PubMed : 7683654, PubMed : 7876104). Plays a major role in the angiotensin-renin system that regulates blood pressure and sodium retention by the kidney by converting angiotensin I to angiotensin II, resulting in an increase of the vasoconstrictor activity of angiotensin (PubMed : 11432860, PubMed : 1851160, PubMed : 19773553, PubMed : 23056909, PubMed : 4322742). Also able to inactivate bradykinin, a potent vasodilator, and therefore enhance the blood pressure response (PubMed : 15615692, PubMed : 2558109, PubMed : 4322742, PubMed : 6055465, PubMed : 6270633, PubMed : 7683654). Acts as a regulator of synaptic transmission by mediating cleavage of neuropeptide hormones, such as substance P, neurotensin or enkephalins (PubMed : 15615692, PubMed : 6208535, PubMed : 6270633, PubMed : 656131). Catalyzes degradation of different enkephalin neuropeptides (Met-enkephalin, Leu-enkephalin, Met-enkephalin-Arg-Phe and possibly Met-enkephalin-Arg-Gly-Leu) (PubMed : 2982830, PubMed : 6270633, PubMed : 656131). Acts as a regulator of synaptic plasticity in the nucleus accumbens of the brain by mediating cleavage of Met-enkephalin-Arg-Phe, a strong ligand of Mu-type opioid receptor OPRM1, into Met-enkephalin (By similarity). Met-enkephalin-Arg-Phe cleavage by ACE decreases activation of OPRM1, leading to long-term synaptic potentiation of glutamate release (By similarity). Also acts as a regulator of hematopoietic stem cell differentiation by mediating degradation of hemoregulatory peptide N-acetyl-SDKP (AcSDKP) (PubMed : 26403559, PubMed : 7876104, PubMed : 8257427, PubMed : 8609242). Acts as a regulator of cannabinoid signaling pathway by mediating degradation of hemopressin, an antagonist peptide of the cannabinoid receptor CNR1 (PubMed : 18077343). Involved in amyloid-beta metabolism by catalyzing degradation of Amyloid-beta protein 40 and Amyloid-beta protein 42 peptides, thereby preventing plaque formation (PubMed : 11604391, PubMed : 16154999, PubMed : 19773553). Catalyzes cleavage of cholecystokinin (maturation of Cholecystokinin-8 and Cholecystokinin-5) and Gonadoliberin-1 (both maturation and degradation) hormones (PubMed : 10336644, PubMed : 2983326, PubMed : 7683654, PubMed : 9371719). Degradation of hemoregulatory peptide N-acetyl-SDKP (AcSDKP) and amyloid-beta proteins is mediated by the N-terminal catalytic domain, while angiotensin I and cholecystokinin cleavage is mediated by the C-terminal catalytic region (PubMed : 10336644, PubMed : 19773553, PubMed : 7876104).. Angiotensin-converting enzyme, soluble form. Soluble form that is released in blood plasma and other body fluids following proteolytic cleavage in the juxtamembrane stalk region.. Isoform Testis-specific. Isoform produced by alternative promoter usage that is specifically expressed in spermatocytes and adult testis, and which is required for male fertility (PubMed : 1651327, PubMed : 1668266). In contrast to somatic isoforms, only contains one catalytic domain (PubMed : 1651327, PubMed : 1668266). Acts as a dipeptidyl carboxypeptidase that removes dipeptides from the C-terminus of substrates (PubMed : 1668266, PubMed : 24297181). The identity of substrates that are needed for male fertility is unknown (By similarity). May also have a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. The GPIase activity was reported to be essential for the egg-binding ability of the sperm (By similarity). This activity is however unclear and has been challenged by other groups, suggesting that it may be indirect (By similarity).
See full target information ACE

Additional targets

ACE2

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
websiteProtocolBooklet
en

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com